These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 June. The technology gains life-saving medical insights by analysing human excrement. D'Firma huet eng Serie vun dräi Patenter ofginn, déi Elementer vu sengem medizinesche Toilettesensor ofdecken.

Three Toilets Detection Health Technologies

The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Europa, Japan a China.

A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, D'Technologie vun OutSense kann d'Quell vum Blutt laanscht de Magen-Darmtrakt identifizéieren.

A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

Laut OutSense CEO Yfat Scialom, who predicts that “mat der Explosioun vun der digitaler Medizin, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, entzündlech Darmkrankheeten an Harnweeër Infektiounen.

Its solution consists of a multispectral optical sensor, eng Liichtquell an en autonomen Screening-Apparat deen eng WiFi Verbindung enthält. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.

OutSense has developed tools to diagnose abnormalities in human excreta. Informatioun kritt aus probe Blutt, kombinéiert mat zousätzlech Analyse vun der Zäit vu Blutungen bis Ausscheedung, liwwert Detailer vun der Blut Pathologie. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.

At the beginning of June, OutSense huet ugekënnegt datt CommuniCare, eng grouss Gesondheetsbetrib mat méi wéi 90 healthcare facilities in the US, wäert ufänken seng Technologie dëst Joer ze pilotéieren. Zousätzlech zu dësem Pilot, OutSense also plans to conduct clinical trials in Israel and Japan.

Visit More News at Viga.cc News